US 8956828
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
granted A61KA61K2239/48A61K35/00
Quick answer
US patent 8956828 (Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases) held by Sangamo Biosciences, Inc. expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Biosciences, Inc.
- Grant date
- Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2239/48, A61K35/00, A61K35/28, A61K38/00